Skip to main content
Clinical Trials/JPRN-UMIN000020395
JPRN-UMIN000020395
Completed
未知

A study to evaluate the usefulness of contrast medium 'Sonazoid; Perflubutane' in EUS diagnosis for pancreaticobiliary tumors. - Usefulness of contrast medium Sonazoid in EUS diagnosis for pancreaticobiliary tumors.

Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine. Kansai Medical University Hirakata Hospital0 sites100 target enrollmentJanuary 4, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
pancreaticobiliary neoplastic lesions that require EUS
Sponsor
Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine. Kansai Medical University Hirakata Hospital
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 4, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine. Kansai Medical University Hirakata Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Cases under 20 years old Cases without written informed consent Cases with allergy for Sonazoid; Perflubutane Cases with possibility of pregnant Cases considered ineligible for this study

Outcomes

Primary Outcomes

Not specified

Similar Trials